A meta-analysis of the efficacy of allopurinol in reducing the incidence of myocardial infarction following coronary artery bypass grafting.

Tejas P SinghTristan SkalinaDaniel NourAarya MuraliSean MorrisonJoseph V MoxonJonathan Golledge

Published in: BMC cardiovascular disorders (2018)

Based on the limited evidence available, allopurinol appears to reduce the incidence of perioperative MI following CABG. Further research is required to confirm these findings.

Keyphrases

coronary artery bypass grafting
coronary artery disease
percutaneous coronary intervention
risk factors
heart failure
patients undergoing
left ventricular
acute coronary syndrome